Study Explores Impact of FDA Approval of Aducanumab on Trial Participation
TUESDAY, Dec. 6, 2022 (HealthDay News) — The U.S. Food and Drug Administration decision to approve aducanumab may have negatively impacted willingness to participate in preclinical Alzheimer disease (AD) trials, according to a study published online …
Learn MoreEducational Attainment No Worse for Children With T1DM
TUESDAY, Dec. 6, 2022 (HealthDay News) — Children with type 1 diabetes do not have worse educational attainment or entry into higher education, despite missing more school, according to a study published in the December issue of Diabetes Care.Robert …
Learn MoreFacial Scars Do Not Affect Perceived Attractiveness, Confidence
TUESDAY, Dec. 6, 2022 (HealthDay News) — A single well-healed facial scar does not negatively affect first impressions of attractiveness, confidence, or friendliness, but specific scar location and orientation may result in lower perceived attractive…
Learn MoreBromocriptine Quick Release Beneficial for Teens With T1DM
TUESDAY, Dec. 6, 2022 (HealthDay News) — For adolescents with type 1 diabetes (T1D), bromocriptine quick release (BCQR) improves blood pressure and central and peripheral aortic stiffness, according to a study published online Dec. 6 in Hypertension….
Learn MoreReview Links Hearing Aid Devices With Reduced Cognitive Decline
TUESDAY, Dec. 6, 2022 (HealthDay News) — For individuals with hearing loss, use of hearing aid devices is associated with a reduced risk for long-term cognitive decline, according to a review published online Dec. 5 in JAMA Neurology.Brian Sheng Yep …
Learn More2013 to 2017 Saw Significant Drop in U.S. Melanoma Mortality Rates
TUESDAY, Dec. 6, 2022 (HealthDay News) — The introduction of new melanoma treatments coincided with a reduction in the melanoma mortality rate (MMR) in the United States, according to a study published online Dec. 6 in JAMA Network Open.Navkirat Kahl…
Learn MoreTeam Care With Clinical Decision Support System Beneficial for T2DM Patients
TUESDAY, Dec. 6, 2022 (HealthDay News) — For patients with uncontrolled type 2 diabetes and comorbid conditions, team-based care with a clinical decision support system (CDSS) significantly reduces cardiovascular risk factors compared with team-based…
Learn MoreDapagliflozin Reduces Hospitalizations Among Patients With CKD
TUESDAY, Dec. 6, 2022 (HealthDay News) — For patients with chronic kidney disease (CKD), dapagliflozin reduces the risk for hospitalization, according to a study published online Dec. 6 in the Annals of Internal Medicine.Meir Schechter, M.D., from th…
Learn MoreHIV Care Services Resilient During COVID-19 Pandemic
MONDAY, Dec. 5, 2022 (HealthDay News) — The HIV prevention and care service was resilient during the COVID-19 pandemic, and services partially rebounded in quarter 3 (Q3) of 2020 following a decline in Q2, according to research published in the Dec….
Learn More41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection
MONDAY, Dec. 5, 2022 (HealthDay News) — More than 40 percent of U.S. adults have serology indicative of past COVID-19 infection, of whom 43.7 percent report never having had COVID-19, according to research published in the Dec. 2 issue of the U.S. C…
Learn More